test

Raymond Debbane

@Siren, L.l.c.

Latest period2024 - Q3ReportedManaged Assets$2BTotal holdings110
Assets growth rate0%Assets growth rate (2-Q avg)0%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Siren, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 110 positions.

Assets under management

The assets under management (AUM) of Siren, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2B in assets, with a quarterly growth rate of 0% and a 2-quarter average growth rate of 0%. The portfolio is managed by Raymond Debbane, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CGEMCullinan Therapeutics Inc
Recent Activity
New Position
1.02%
$20.278M
1.211M shares@ $16.74 avg price
TNGXTango Therapeutics Inc
Recent Activity
New Position
1.01%
$20.05M
2.604M shares@ $7.71 avg price
SLDBSolid Biosciences Inc
Recent Activity
New Position
0.96%
$19.161M
2.749M shares@ $6.98 avg price
PRTAProthena Corporation Plc
Recent Activity
New Position
0.92%
$18.4M
1.1M shares@ $16.73 avg price
NAMSNewamsterdam Pharma Company Nv
Recent Activity
New Position
0.77%
$15.281M
920,564 shares@ $16.6 avg price
BHVNBiohaven Ltd
Recent Activity
New Position
0.71%
$14.168M
283,540 shares@ $49.98 avg price
KRROKorro Bio Inc
Recent Activity
New Position
0.7%
$13.997M
418,833 shares@ $33.43 avg price
APLTApplied Therapeutics Inc
Recent Activity
New Position
0.7%
$13.887M
1.634M shares@ $8.5 avg price
GOSSGossamer Bio Inc
Recent Activity
New Position
0.67%
$13.305M↑ Call
13.489M shares@ $0.99 avg price
TILInstil Bio Inc
Recent Activity
New Position
0.65%
$12.955M
192,433 shares@ $67.33 avg price